PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
May 11, 2026EXPERIMENTAL ANIMALSOpen Access

Resveratrol alleviates endometriosis via restoration of hypoxic milieu and inhibition of autoantibody deposition

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYi LUOMKMio KobayashiDZDi Zhang

Discussion

Loading...

Member takes

Overview

Randomized trial reveals resveratrol reduces endometriotic lesions in a murine model, suggesting a new treatment approach.

Key Points

  • This study aims to explore a novel mechanism of endometriosis and evaluate the therapeutic potential of resveratrol.
  • Used a murine model of endometriosis to induce hypoxic conditions, indicated by HIF-1α expression.
  • Administered resveratrol to evaluate its effects on endometriotic lesion size and weight.
  • Assessed levels of autoantibody deposition in endometriotic lesions.
  • Resveratrol administration reduced the size and weight of endometriotic lesions significantly.
  • HIF-1α–positive cell counts decreased after resveratrol treatment.
  • Autoantibody accumulation in endometriotic lesions was inhibited in resveratrol-treated mice.

Cite This Study

LUO et al. (2026) studied this question.

synapsesocial.com/papers/6a0171983a9f334c28271aeehttps://doi.org/10.1538/expanim.26-0002
View Full Paper
Ask AI
Bookmark
Share